2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 348.373 | 351.458 | 316.021 | 319.453 | 330.563 | 297.686 | 300.127 | 298.118 | 323.522 | 339.819 |
Total Income - EUR | 349.099 | 352.550 | 316.023 | 319.507 | 330.565 | 308.056 | 318.946 | 298.120 | 323.524 | 339.822 |
Total Expenses - EUR | 354.034 | 357.108 | 320.293 | 314.960 | 333.610 | 311.285 | 289.916 | 294.242 | 320.519 | 320.103 |
Gross Profit/Loss - EUR | -4.935 | -4.558 | -4.271 | 4.547 | -3.045 | -3.228 | 29.030 | 3.878 | 3.005 | 19.719 |
Net Profit/Loss - EUR | -5.021 | -4.911 | -4.771 | 1.233 | -6.526 | -6.444 | 25.965 | 800 | -375 | 16.184 |
Employees | 10 | 0 | 0 | 10 | 8 | 9 | 11 | 9 | 8 | 6 |
Check the financial reports for the company - Farmacia Essential Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 21.209 | 25.521 | 21.521 | 16.923 | 12.512 | 16.668 | 13.776 | 10.951 | 25.108 | 18.609 |
Current Assets | 131.061 | 102.762 | 89.512 | 99.330 | 90.355 | 88.864 | 101.417 | 93.224 | 92.779 | 117.471 |
Inventories | 79.372 | 69.928 | 71.754 | 67.227 | 55.448 | 56.441 | 62.739 | 60.040 | 58.824 | 83.442 |
Receivables | 50.356 | 29.834 | 14.298 | 27.179 | 32.889 | 30.560 | 36.202 | 30.377 | 33.261 | 30.121 |
Cash | 1.333 | 3.000 | 3.459 | 4.924 | 2.018 | 1.864 | 2.475 | 2.807 | 694 | 3.908 |
Shareholders Funds | 26.542 | 21.852 | 16.858 | 17.806 | 10.953 | 4.298 | 30.181 | 8.075 | 7.726 | 23.887 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 126.607 | 107.497 | 94.505 | 98.501 | 91.913 | 101.899 | 85.231 | 96.099 | 110.161 | 112.193 |
Income in Advance | 0 | 46 | 56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Farmacia Essential Srl